Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata. Tavoletti G, Chiei-Gallo A, Barei F, Marzano AV, et al. Int J Dermatol 2024 Jan 10. doi: 10.1111/ijd.17010.

Read + Share

Amedeo Smart

Independent Medical Education

Tavoletti G, Chiei-Gallo A, Barei F, Marzano AV, et al. Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata. Int J Dermatol 2024 Jan 10. doi: 10.1111/ijd.17010.
PMID: 38197323